Targeting Nrf2-Keap1 signaling for chemoprevention of skin carcinogenesis with bioactive phytochemicals

Toxicology Letters

Volumn 229, Issue 1, 2014, Pages 73-84

  Chun, Kyung Soo ^a   Kundu, Juthika ^a   Kundu, Joydeb Kumar ^a   Surh, Young Joon ^b  

^a Keimyung University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Antioxidant response elements; Chemoprevention; Heme oxygenase 1; Nrf2; Phytochemicals; Skin cancer

Indexed keywords

CARCINOGEN; CELASTROL; CURCUMIN; ELLAGIC ACID; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LUCIDONE; MYRICETIN; ORGANOSULFUR DERIVATIVE; PHENETHYL ISOTHIOCYANATE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; SULFORAPHANE; THYMOQUINONE; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ZERUMBONE;

ANTIOXIDANT RESPONSIVE ELEMENT; CANCER PREVENTION; DETOXIFICATION; GENE EXPRESSION; HUMAN; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; SKIN CARCINOGENESIS; SKIN FIBROBLAST; SOLAR RADIATION; SQUAMOUS CELL CARCINOMA; TRANSCRIPTION INITIATION; ULTRAVIOLET IRRADIATION;

ANTIOXIDANT RESPONSE ELEMENTS; CHEMOPREVENTION; HEME OXYGENASE-1; NRF2; PHYTOCHEMICALS; SKIN CANCER;

ANIMALS; ANTICARCINOGENIC AGENTS; BIOTRANSFORMATION; CARCINOGENESIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; NF-E2-RELATED FACTOR 2; PHYTOCHEMICALS; SKIN NEOPLASMS;

EID: 84903202557     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2014.05.018     Document Type: Review

References (142)

1. Agrawal D.K., Mishra P.K. Curcumin and its analogues: potential anticancer agents. Med. Res. Rev. 2010, 30:818-860.
2. Allanson M., Reeve V.E. Carbon monoxide signalling reduces photocarcinogenesis in the hairless mouse. Cancer Immunol. Immunother. 2007, 56:1807-1815.
3. Allison A.C., Cacabelos R., Lombardi V.R., Alvarez X.A., Vigo C. Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25:1341-1357.
4. Amiot M.J., Romier B., Dao T.M., Fanciullino R., Ciccolini J., Burcelin R., Pechere L., Emond C., Savouret J.F., Seree E. Optimization of trans-resveratrol bioavailability for human therapy. Biochimie 2013, 95:1233-1238.
5. Amstad P.A., Liu H., Ichimiya M., Berezesky I.K., Trump B.F. Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis 1997, 18:479-484.
6. Ananthaswamy H.N., Kanjilal S. Oncogenes and tumor suppressor genes in photocarcinogenesis. Photochem. Photobiol. 1996, 63:428-432.
7. Ashurst S.W., Cohen G.M. In vivo formation of benzo(alpha)pyrene diol epoxide-deoxyadenosine adducts in the skin of mice susceptible to benzo(alpha)pyrene-induced carcinogenesis. Int. J. Cancer 1981, 27:357-364.
8. Aziz M.H., Reagan-Shaw S., Wu J., Longley B.J., Ahmad N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?. FASEB J. 2005, 19:1193-1195.
9. Bae J.Y., Choi J.S., Kang S.W., Lee Y.J., Park J., Kang Y.H. Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp. Dermatol. 2010, 19:e182-e190.
10. Baliga M.S., Katiyar S.K. Chemoprevention of photocarcinogenesis by selected dietary botanicals. Photochem. Photobiol. Sci. 2006, 5:243-253.
11. Cai X., Fang Z., Dou J., Yu A., Zhai G. Bioavailability of quercetin: problems and promises. Curr. Med. Chem. 2013, 20:2572-2582.
12. Chen C., Pung D., Leong V., Hebbar V., Shen G., Nair S., Li W., Kong A.N. Induction of detoxifying enzymes by garlic organosulfur compounds through transcription factor Nrf2: effect of chemical structure and stress signals. Free Radic. Biol. Med. 2004, 37:1578-1590.
13. Chen L., Hu J.Y., Wang S.Q. The role of antioxidants in photoprotection: a critical review. J. Am. Acad. Dermatol. 2012, 67:1013-1024.
14. Chen Y., Wu Q., Zhang Z., Yuan L., Liu X., Zhou L. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules 2012, 17:5972-5987.
15. Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., Ko J.Y., Lin J.T., Lin B.R., Ming-Shiang W., Yu H.S., Jee S.H., Chen G.S., Chen T.M., Chen C.A., Lai M.K., Pu Y.S., Pan M.H., Wang Y.J., Tsai C.C., Hsieh C.Y. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001, 21:2895-2900.
16. Cheung K.L., Kong A.N. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J. 2010, 12:87-97.
17. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., Zarzuelo A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur. J. Immunol. 2005, 35:584-592.
18. Cooke M.S., Evans M.D., Dizdaroglu M., Lunec J. Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J. 2003, 17:1195-1214.
19. Crawford D.R., Amstad P.A., Foo D.D., Cerutti P.A. Constitutive and phorbol-myristate-acetate regulated antioxidant defense of mouse epidermal JB6 cells. Mol. Carcinog. 1989, 2:136-143.
20. Dhakshinamoorthy S., Jain A.K., Bloom D.A., Jaiswal A.K. Bach1 competes with Nrf2 leading to negative regulation of the antioxidant response element (ARE)-mediated NAD(P)H:quinone oxidoreductase 1 gene expression and induction in response to antioxidants. J. Biol. Chem. 2005, 280:16891-16900.
21. Dhar S.K., Xu Y., Noel T., St Clair D.K. Chronic exposure to 12-O-tetradecanoylphorbol-13-acetate represses sod2 induction in vivo: the negative role of p50. Carcinogenesis 2007, 28:2605-2613.
22. Ding M., Zhao J., Bowman L., Lu Y., Shi X. Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin. Int. J. Oncol. 2010, 36:59-67.
23. Dinkova-Kostova A.T. Phytochemicals as protectors against ultraviolet radiation: versatility of effects and mechanisms. Planta Med. 2008, 74:1548-1559.
24. Dinkova-Kostova A.T., Fahey J.W., Wade K.L., Jenkins S.N., Shapiro T.A., Fuchs E.J., Kerns M.L., Talalay P. Induction of the phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol. Biomark. Prev. 2007, 16:847-851.
25. Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:11908-11913.
26. Dinkova-Kostova A.T., Jenkins S.N., Wehage S.L., Huso D.L., Benedict A.L., Stephenson K.K., Fahey J.W., Liu H., Liby K.T., Honda T., Gribble G.W., Sporn M.B., Talalay P. A dicyanotriterpenoid induces cytoprotective enzymes and reduces multiplicity of skin tumors in UV-irradiated mice. Biochem. Biophys. Res. Commun. 2008, 367:859-865.
27. Dwivedi C., Rohlfs S., Jarvis D., Engineer F.N. Chemoprevention of chemically induced skin tumor development by diallyl sulfide and diallyl disulfide. Pharm. Res. 1992, 9:1668-1670.
28. England K., Cotter T.G. Direct oxidative modifications of signalling proteins in mammalian cells and their effects on apoptosis. Redox Rep. 2005, 10:237-245.
29. Fisher C.D., Augustine L.M., Maher J.M., Nelson D.M., Slitt A.L., Klaassen C.D., Lehman-McKeeman L.D., Cherrington N.J. Induction of drug-metabolizing enzymes by garlic and allyl sulfide compounds via activation of constitutive androstane receptor and nuclear factor E2-related factor 2. Drug Metab. Dispos. 2007, 35:995-1000.
30. Fisher M.S., Kripke M.L. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 1982, 216:1133-1134.
31. Frenkel K., Wei L., Wei H. 7,12-Dimethylbenz[a]anthracene induces oxidative DNA modification in vivo. Free Radic. Biol. Med. 1995, 19:373-380.
32. Fuchs J., Huflejt M.E., Rothfuss L.M., Wilson D.S., Carcamo G., Packer L. Impairment of enzymic and nonenzymic antioxidants in skin by UVB irradiation. J. Invest. Dermatol. 1989, 93:769-773.
33. Gokce E.H., Korkmaz E., Dellera E., Sandri G., Bonferoni M.C., Ozer O. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int. J. Nanomed. 2012, 7:1841-1850.
34. Grover P.L., Hewer A., Pal K., Sims P. The involvement of a diol-epoxide in the metabolic activation of benzo(a)pyrene in human bronchial mucosa and in mouse skin. Int. J. Cancer 1976, 18:1-6.
35. Gupta A., Butts B., Kwei K.A., Dvorakova K., Stratton S.P., Briehl M.M., Bowden G.T. Attenuation of catalase activity in the malignant phenotype plays a functional role in an in vitro model for tumor progression. Cancer Lett. 2001, 173:115-125.
36. Halliday G.M. Inflammation, gene mutation and photoimmunosuppression in response to UVR-induced oxidative damage contributes to photocarcinogenesis. Mutat. Res. 2005, 571:107-120.
37. Hamanaka H., Miyachi Y., Tachibana T., Imamura S. Lowered Cu, Zn-superoxide dismutase activity in human malignant skin tumors. J. Dermatol. 1991, 18:258-261.
38. Henderson C.J., Smith A.G., Ure J., Brown K., Bacon E.J., Wolf C.R. Increased skin tumorigenesis in mice lacking pi class glutathione S-transferases. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:5275-5280.
39. Hseu Y.C., Chou C.W., Senthil Kumar K.J., Fu K.T., Wang H.M., Hsu L.S., Kuo Y.H., Wu C.R., Chen S.C., Yang H.L. Ellagic acid protects human keratinocyte (HaCaT) cells against UVA-induced oxidative stress and apoptosis through the upregulation of the HO-1 and Nrf-2 antioxidant genes. Food Chem. Toxicol. 2012, 50:1245-1255.
40. Hu C., Eggler A.L., Mesecar A.D., van Breemen R.B. Modification of keap1 cysteine residues by sulforaphane. Chem. Res. Toxicol. 2011, 24:515-521.
41. Huang H.C., Nguyen T., Pickett C.B. Phosphorylation of Nrf2 at Ser-40 by protein kinase C regulates antioxidant response element-mediated transcription. J. Biol. Chem. 2002, 277:42769-42774.
42. Huang M.T., Ma W., Lu Y.P., Chang R.L., Fisher C., Manchand P.S., Newmark H.L., Conney A.H. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 1995, 16:2493-2497.
43. Hussein M.R. Ultraviolet radiation and skin cancer: molecular mechanisms. J. Cutan. Pathol. 2005, 32:191-205.
44. Iskander K., Gaikwad A., Paquet M., Long D.J., Brayton C., Barrios R., Jaiswal A.K. Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis. Cancer Res. 2005, 65:2054-2058.
45. Itoh K., Chiba T., Takahashi S., Ishii T., Igarashi K., Katoh Y., Oyake T., Hayashi N., Satoh K., Hatayama I., Yamamoto M., Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 1997, 236:313-322.
46. Jain A.K., Jaiswal A.K. GSK-3beta acts upstream of Fyn kinase in regulation of nuclear export and degradation of NF-E2 related factor 2. J. Biol. Chem. 2007, 282:16502-16510.
47. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
48. Jung S.K., Lee K.W., Byun S., Kang N.J., Lim S.H., Heo Y.S., Bode A.M., Bowden G.T., Lee H.J., Dong Z. Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res. 2008, 68:6021-6029.
49. Jyrkkanen H.K., Kuosmanen S., Heinaniemi M., Laitinen H., Kansanen E., Mella-Aho E., Leinonen H., Yla-Herttuala S., Levonen A.L. Novel insights into the regulation of antioxidant-response-element-mediated gene expression by electrophiles: induction of the transcriptional repressor BACH1 by Nrf2. Biochem. J. 2011, 440:167-174.
50. Kalra S., Zhang Y., Knatko E.V., Finlayson S., Yamamoto M., Dinkova-Kostova A.T. Oral azathioprine leads to higher incorporation of 6-thioguanine in DNA of skin than liver: the protective role of the Keap1/Nrf2/ARE pathway. Cancer Prev. Res. (Phila.) 2011, 4:1665-1674.
51. Kanai M., Imaizumi A., Otsuka Y., Sasaki H., Hashiguchi M., Tsujiko K., Matsumoto S., Ishiguro H., Chiba T. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother. Pharmacol. 2012, 69:65-70.
52. Kannan S., Jaiswal A.K. Low and high dose UVB regulation of transcription factor NF-E2-related factor 2. Cancer Res. 2006, 66:8421-8429.
53. Katoh Y., Itoh K., Yoshida E., Miyagishi M., Fukamizu A., Yamamoto M. Two domains of Nrf2 cooperatively bind CBP, a CREB binding protein, and synergistically activate transcription. Genes Cells 2001, 6:857-868.
54. Kawachi Y., Xu X., Taguchi S., Sakurai H., Nakamura Y., Ishii Y., Fujisawa Y., Furuta J., Takahashi T., Itoh K., Yamamoto M., Yamazaki F., Otsuka F. Attenuation of UVB-induced sunburn reaction and oxidative DNA damage with no alterations in UVB-induced skin carcinogenesis in Nrf2 gene-deficient mice. J. Invest. Dermatol. 2008, 128:1773-1779.
55. Keum Y.S. Regulation of the Keap1/Nrf2 system by chemopreventive sulforaphane: implications of posttranslational modifications. Ann. N.Y. Acad. Sci. 2011, 1229:184-189.
56. Keum Y.S., Yu S., Chang P.P., Yuan X., Kim J.H., Xu C., Han J., Agarwal A., Kong A.N. Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res. 2006, 66:8804-8813.
57. Khalil N.M., do Nascimento T.C., Casa D.M., Dalmolin L.F., de Mattos A.C., Hoss I., Romano M.A., Mainardes R.M. Pharmacokinetics of curcumin-loaded PLGA and PLGA-PEG blend nanoparticles after oral administration in rats. Colloids Surf. B Biointerfaces 2013, 101:353-360.
58. Khan N., Afaq F., Mukhtar H. Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid. Redox Signal. 2008, 10:475-510.
59. Kim S.H., Kim M.O., Gao P., Youm C.A., Park H.R., Lee T.S., Kim K.S., Suh J.G., Lee H.T., Park B.J., Ryoo Z.Y., Lee T.H. Overexpression of extracellular superoxide dismutase (EC-SOD) in mouse skin plays a protective role in DMBA/TPA-induced tumor formation. Oncol. Res. 2005, 15:333-341.
60. Kimura S., Warabi E., Yanagawa T., Ma D., Itoh K., Ishii Y., Kawachi Y., Ishii T. Essential role of Nrf2 in keratinocyte protection from UVA by quercetin. Biochem. Biophys. Res. Commun. 2009, 387:109-114.
61. Kleszczynski K., Ernst I.M., Wagner A.E., Kruse N., Zillikens D., Rimbach G., Fischer T.W. Sulforaphane and phenylethyl isothiocyanate protect human skin against UVR-induced oxidative stress and apoptosis: role of Nrf2-dependent gene expression and antioxidant enzymes. Pharmacol. Res. 2013, 78:28-40.
62. Kumar R., Ansari K.M., Chaudhari B.P., Dhawan A., Dwivedi P.D., Jain S.K., Das M. Topical application of ochratoxin A causes DNA damage and tumor initiation in mouse skin. PLoS ONE 2012, 7:e47280.
63. Kundu J., Kim D.H., Kundu J.K., Chun K.S. Thymoquinone induces heme oxygenase-1 expression in HaCaT cells via Nrf2/ARE activation: Akt and AMPKalpha as upstream targets. Food Chem. Toxicol. 2014, 65:18-26.
64. Kundu J.K., Hwang D.M., Lee J.C., Chang E.J., Shin Y.K., Fujii H., Sun B., Surh Y.J. Inhibitory effects of oligonol on phorbol ester-induced tumor promotion and COX-2 expression in mouse skin: NF-kappaB and C/EBP as potential targets. Cancer Lett. 2009, 273:86-97.
65. Kundu J.K., Liu L., Shin J.W., Surh Y.J. Thymoquinone inhibits phorbol ester-induced activation of NF-kappaB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo. Biochem. Biophys. Res. Commun. 2013, 438:721-727.
66. Kundu J.K., Surh Y.J. Nrf2-Keap1 signaling as a potential target for chemoprevention of inflammation-associated carcinogenesis. Pharm. Res. 2010, 27:999-1013.
67. Kwak M.K., Wakabayashi N., Kensler T.W. Chemoprevention through the Keap1-Nrf2 signaling pathway by phase 2 enzyme inducers. Mutat. Res. 2004, 555:133-148.
68. Kwei K.A., Finch J.S., Thompson E.J., Bowden G.T. Transcriptional repression of catalase in mouse skin tumor progression. Neoplasia 2004, 6:440-448.
69. Lazovich D., Choi K., Vogel R.I. Time to get serious about skin cancer prevention. Cancer Epidemiol. Biomark. Prev. 2012, 21:1893-1901.
70. Lima C.F., Pereira-Wilson C., Rattan S.I. Curcumin induces heme oxygenase-1 in normal human skin fibroblasts through redox signaling: relevance for anti-aging intervention. Mol. Nutr. Food Res. 2011, 55:430-442.
71. Liu Y., Chan F., Sun H., Yan J., Fan D., Zhao D., An J., Zhou D. Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression. Eur. J. Pharmacol. 2011, 650:130-137.
72. Lo S.C., Hannink M. PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria. Exp. Cell Res. 2008, 314:1789-1803.
73. Loboda A., Was H., Jozkowicz A., Dulak J. Janus face of Nrf2-HO-1 axis in cancer-friend in chemoprevention, foe in anticancer therapy. Lung Cancer 2008, 60:1-3.
74. Long D.J., Waikel R.L., Wang X.J., Perlaky L., Roop D.R., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res. 2000, 60:5913-5915.
75. Long D.J., Waikel R.L., Wang X.J., Roop D.R., Jaiswal A.K. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J. Natl. Cancer Inst. 2001, 93:1166-1170.
76. Lucas R.M., McMichael A.J., Armstrong B.K., Smith W.T. Estimating the global disease burden due to ultraviolet radiation exposure. Int. J. Epidemiol. 2008, 37:654-667.
77. MacLeod A.K., McMahon M., Plummer S.M., Higgins L.G., Penning T.M., Igarashi K., Hayes J.D. Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1-NRF2 pathway, and not the BACH1-NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds. Carcinogenesis 2009, 30:1571-1580.
78. Marnett L.J. Oxyradicals and DNA damage. Carcinogenesis 2000, 21:361-370.
79. Martin D., Rojo A.I., Salinas M., Diaz R., Gallardo G., Alam J., De Galarreta C.M., Cuadrado A. Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol. J. Biol. Chem. 2004, 279:8919-8929.
80. Menon V.P., Sudheer A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 2007, 595:105-125.
81. Min Y.D., Choi C.H., Bark H., Son H.Y., Park H.H., Lee S., Park J.W., Park E.K., Shin H.I., Kim S.H. Quercetin inhibits expression of inflammatory cytokines through attenuation of NF-kappaB and p38 MAPK in HMC-1 human mast cell line. Inflamm. Res. 2007, 56:210-215.
82. Mo C., Wang L., Zhang J., Numazawa S., Tang H., Xiaoqiang T., Han X., Li J., Yang M., Wang Z., Wei D., Xiao H. The crosstalk between Nrf2 and AMPK pathways is important for the anti-inflammatory effect of berberine in LPS-stimulated macrophages and endotoxin-shocked mice. Antioxid. Redox Signal. 2013, 20:574-588.
83. Moyano-Mendez J.R., Fabbrocini G., De Stefano D., Mazzella C., Mayol L., Scognamiglio I., Carnuccio R., Ayala F., La Rotonda M.I., De Rosa G. Enhanced antioxidant effect of trans-resveratrol: potential of binary systems with polyethylene glycol and cyclodextrin. Drug Dev. Ind. Pharm. 2013, [Epub ahead of print].
84. Murakami A., Tanaka T., Lee J.Y., Surh Y.J., Kim H.W., Kawabata K., Nakamura Y., Jiwajinda S., Ohigashi H. Zerumbone, a sesquiterpene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int. J. Cancer 2004, 110:481-490.
85. Mutanen M., Pajari A.M., Paivarinta E., Misikangas M., Rajakangas J., Marttinen M., Oikarinen S. Berries as chemopreventive dietary constituents-a mechanistic approach with the ApcMin/+ mouse. Asia Pac. J. Clin. Nutr. 2008, 17(Suppl. 1):123-125.
86. Nair M.P., Mahajan S., Reynolds J.L., Aalinkeel R., Nair H., Schwartz S.A., Kandaswami C. The flavonoid quercetin inhibits proinflammatory cytokine (tumor necrosis factor alpha) gene expression in normal peripheral blood mononuclear cells via modulation of the NF-kappa beta system. Clin. Vaccine Immunol. 2006, 13:319-328.
87. Nakamura Y., Colburn N.H., Gindhart T.D. Role of reactive oxygen in tumor promotion: implication of superoxide anion in promotion of neoplastic transformation in JB-6 cells by TPA. Carcinogenesis 1985, 6:229-235.
88. Nirmala P., Ramanathan M. Effect of myricetin on 1,2-dimethylhydrazine induced rat colon carcinogenesis. J. Exp. Ther. Oncol. 2011, 9:101-108.
89. Nishigori C., Hattori Y., Toyokuni S. Role of reactive oxygen species in skin carcinogenesis. Antioxid. Redox Signal. 2004, 6:561-570.
90. Panahi Y., Sahebkar A., Amiri M., Davoudi S.M., Beiraghdar F., Hoseininejad S.L., Kolivand M. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 2012, 108:1272-1279.
91. Park G., Kim H.G., Kim Y.O., Park S.H., Kim S.Y., Oh M.S. Coriandrum sativum L. protects human keratinocytes from oxidative stress by regulating oxidative defense systems. Skin Pharmacol. Physiol. 2012, 25:93-99.
92. Pence B.C., Naylor M.F. Effects of single-dose ultraviolet radiation on skin superoxide dismutase, catalase, and xanthine oxidase in hairless mice. J. Invest. Dermatol. 1990, 95:213-216.
93. Rachmawati H., Budiputra D.K., Mauludin R. Curcumin nanoemulsion for transdermal application: formulation and evaluation. Drug Dev. Ind. Pharm. 2014, [Epub ahead of print].
94. Raval C.M., Zhong J.L., Mitchell S.A., Tyrrell R.M. The role of Bach1 in ultraviolet A-mediated human heme oxygenase 1 regulation in human skin fibroblasts. Free Radic. Biol. Med. 2012, 52:227-236.
95. Reichard J.F., Motz G.T., Puga A. Heme oxygenase-1 induction by NRF2 requires inactivation of the transcriptional repressor BACH1. Nucleic Acids Res. 2007, 35:7074-7086.
96. Rendic S., Guengerich F.P. Contributions of human enzymes in carcinogen metabolism. Chem. Res. Toxicol. 2012, 25:1316-1383.
97. Ryan J.L., Heckler C.E., Ling M., Katz A., Williams J.P., Pentland A.P., Morrow G.R. Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients. Radiat. Res. 2013, 180:34-43.
98. Salomi M.J., Nair S.C., Panikkar K.R. Inhibitory effects of Nigella sativa and saffron (Crocus sativus) on chemical carcinogenesis in mice. Nutr. Cancer 1991, 16:67-72.
99. Sander C.S., Chang H., Hamm F., Elsner P., Thiele J.J. Role of oxidative stress and the antioxidant network in cutaneous carcinogenesis. Int. J. Dermatol. 2004, 43:326-335.
100. Sander C.S., Hamm F., Elsner P., Thiele J.J. Oxidative stress in malignant melanoma and non-melanoma skin cancer. Br. J. Dermatol. 2003, 148:913-922.
101. Sankar P., Telang A.G., Manimaran A. Protective effect of curcumin on cypermethrin-induced oxidative stress in Wistar rats. Exp. Toxicol. Pathol. 2012, 64:487-493.
102. Saw C.L., Huang M.T., Liu Y., Khor T.O., Conney A.H., Kong A.N. Impact of Nrf2 on UVB-induced skin inflammation/photoprotection and photoprotective effect of sulforaphane. Mol. Carcinog. 2011, 50:479-486.
103. Scalia S., Franceschinis E., Bertelli D., Iannuccelli V. Comparative evaluation of the effect of permeation enhancers, lipid nanoparticles and colloidal silica on in vivo human skin penetration of quercetin. Skin Pharmacol. Physiol. 2013, 26:57-67.
104. Schafer M., Dutsch S., auf dem Keller U., Werner S. Nrf2: a central regulator of UV protection in the epidermis. Cell Cycle 2010, 9:2917-2918.
105. Senthil Kumar K.J., Yang H.L., Tsai Y.C., Hung P.C., Chang S.H., Lo H.W., Shen P.C., Chen S.C., Wang H.M., Wang S.Y., Chou C.W., Hseu Y.C. Lucidone protects human skin keratinocytes against free radical-induced oxidative damage and inflammation through the up-regulation of HO-1/Nrf2 antioxidant genes and down-regulation of NF-kappaB signaling pathway. Food Chem. Toxicol. 2013, 59:55-66.
106. Seo W.Y., Ju S.M., Song H.Y., Goh A.R., Jun J.G., Kang Y.H., Choi S.Y., Park J. Celastrol suppresses IFN-gamma-induced ICAM-1 expression and subsequent monocyte adhesiveness via the induction of heme oxygenase-1 in the HaCaT cells. Biochem. Biophys. Res. Commun. 2010, 398:140-145.
107. Sgarbossa A., Dal Bosco M., Pressi G., Cuzzocrea S., Dal Toso R., Menegazzi M. Phenylpropanoid glycosides from plant cell cultures induce heme oxygenase 1 gene expression in a human keratinocyte cell line by affecting the balance of NRF2 and BACH1 transcription factors. Chem. Biol. Interact. 2012, 199:87-95.
108. Shehzad A., Wahid F., Lee Y.S. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch. Pharm. 2010, 343:489-499.
109. Shen G., Hebbar V., Nair S., Xu C., Li W., Lin W., Keum Y.S., Han J., Gallo M.A., Kong A.N. Regulation of Nrf2 transactivation domain activity. The differential effects of mitogen-activated protein kinase cascades and synergistic stimulatory effect of Raf and CREB-binding protein. J. Biol. Chem. 2004, 279:23052-23060.
110. Shen G., Kong A.N. Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. Biopharm. Drug Dispos. 2009, 30:345-355.
111. Shin J.W., Ohnishi K., Murakami A., Lee J.S., Kundu J.K., Na H.K., Ohigashi H., Surh Y.J. Zerumbone induces heme oxygenase-1 expression in mouse skin and cultured murine epidermal cells through activation of Nrf2. Cancer Prev. Res. (Phila.) 2011, 4:860-870.
112. Shindo Y., Witt E., Han D., Packer L. Dose-response effects of acute ultraviolet irradiation on antioxidants and molecular markers of oxidation in murine epidermis and dermis. J. Invest. Dermatol. 1994, 102:470-475.
113. Shindo Y., Witt E., Packer L. Antioxidant defense mechanisms in murine epidermis and dermis and their responses to ultraviolet light. J. Invest. Dermatol. 1993, 100:260-265.
114. Shrotriya S., Kundu J.K., Na H.K., Surh Y.J. Diallyl trisulfide inhibits phorbol ester-induced tumor promotion, activation of AP-1, and expression of COX-2 in mouse skin by blocking JNK and Akt signaling. Cancer Res. 2010, 70:1932-1940.
115. Slaga T.J., Viaje A., Bracken W.M., Berry D.L., Fischer S.M., Miller D.R., Leclerc S.M. Skin-tumor-initiating ability of benzo(a)pyrene-7,8-diol-9,10-epoxide (anti) when applied topically in tetrahydrofuran. Cancer Lett. 1977, 3:23-30.
116. Solanki V., Rana R.S., Slaga T.J. Diminution of mouse epidermal superoxide dismutase and catalase activities by tumor promoters. Carcinogenesis 1981, 2:1141-1146.
117. Stadtman E.R., Levine R.L. Free radical-mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 2003, 25:207-218.
118. Sullivan N.J., Tober K.L., Burns E.M., Schick J.S., Riggenbach J.A., Mace T.A., Bill M.A., Young G.S., Oberyszyn T.M., Lesinski G.B. UV light B-mediated inhibition of skin catalase activity promotes Gr-1+ CD11b+ myeloid cell expansion. J. Invest. Dermatol. 2012, 132:695-702.
119. Sultana S., Alam A., Khan N., Sharma S. Inhibition of benzoyl peroxide and ultraviolet-B radiation induced oxidative stress and tumor promotion markers by cycloartenol in murine skin. Redox Rep. 2003, 8:105-112.
120. Sun Z., Chin Y.E., Zhang D.D. Acetylation of Nrf2 by p300/CBP augments promoter-specific DNA binding of Nrf2 during the antioxidant response. Mol. Cell. Biol. 2009, 29:2658-2672.
121. Surh Y.J., Kundu J.K., Na H.K. Nrf2 as a master redox switch in turning on the cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med. 2008, 74:1526-1539.
122. Talalay P., Fahey J.W., Healy Z.R., Wehage S.L., Benedict A.L., Min C., Dinkova-Kostova A.T. Sulforaphane mobilizes cellular defenses that protect skin against damage by UV radiation. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:17500-17505.
123. Tanigawa S., Fujii M., Hou D.X. Action of Nrf2 and Keap1 in ARE-mediated NQO1 expression by quercetin. Free Radic. Biol. Med. 2007, 42:1690-1703.
124. Tian F.F., Zhang F.F., Lai X.D., Wang L.J., Yang L., Wang X., Singh G., Zhong J.L. Nrf2-mediated protection against UVA radiation in human skin keratinocytes. Biosci. Trends 2011, 5:23-29.
125. Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 2006, 387:1311-1320.
126. Tsai C.Y., Wang C.C., Lai T.Y., Tsu H.N., Wang C.H., Liang H.Y., Kuo W.W. Antioxidant effects of diallyl trisulfide on high glucose-induced apoptosis are mediated by the PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes. Int. J. Cardiol. 2013, 168:1286-1297.
127. Tsai K.D., Lin J.C., Yang S.M., Tseng M.J., Hsu J.D., Lee Y.J., Cherng J.M. Curcumin protects against UVB-induced skin cancers in SKH-1 hairless mouse: analysis of early molecular markers in carcinogenesis. Evid. Based Complement Alternat. Med. 2012, 2012:593952.
128. Tudek B., Winczura A., Janik J., Siomek A., Foksinski M., Olinski R. Involvement of oxidatively damaged DNA and repair in cancer development and aging. Am. J. Transl. Res. 2010, 2:254-284.
129. Vattem D.A., Ghaedian R., Shetty K. Enhancing health benefits of berries through phenolic antioxidant enrichment: focus on cranberry. Asia Pac. J. Clin. Nutr. 2005, 14:120-130.
130. Vienneau D.S., DeBoni U., Wells P.G. Potential genoprotective role for UDP-glucuronosyltransferases in chemical carcinogenesis: initiation of micronuclei by benzo(a)pyrene and benzo(e)pyrene in UDP-glucuronosyltransferase-deficient cultured rat skin fibroblasts. Cancer Res. 1995, 55:1045-1051.
131. Wagner A.E., Ernst I., Iori R., Desel C., Rimbach G. Sulforaphane but not ascorbigen, indole-3-carbinole and ascorbic acid activates the transcription factor Nrf2 and induces phase-2 and antioxidant enzymes in human keratinocytes in culture. Exp. Dermatol. 2010, 19:137-144.
132. Wagner C., Fachinetto R., Dalla Corte C.L., Brito V.B., Severo D., de Oliveira Costa Dias G., Morel A.F., Nogueira C.W., Rocha J.B. Quercitrin, a glycoside form of quercetin, prevents lipid peroxidation in vitro. Brain Res. 2006, 1107:192-198.
133. Wakabayashi N., Dinkova-Kostova A.T., Holtzclaw W.D., Kang M.I., Kobayashi A., Yamamoto M., Kensler T.W., Talalay P. Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:2040-2045.
134. Wakabayashi N., Itoh K., Wakabayashi J., Motohashi H., Noda S., Takahashi S., Imakado S., Kotsuji T., Otsuka F., Roop D.R., Harada T., Engel J.D., Yamamoto M. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 2003, 35:238-245.
135. Was H., Sokolowska M., Sierpniowska A., Dominik P., Skrzypek K., Lackowska B., Pratnicki A., Grochot-Przeczek A., Taha H., Kotlinowski J., Kozakowska M., Mazan A., Nowak W., Muchova L., Vitek L., Ratajska A., Dulak J., Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radic. Biol. Med. 2011, 51:1717-1726.
136. Wattenberg L.W. Chemoprophylaxis of carcinogenesis: a review. Cancer Res. 1966, 26:1520-1526.
137. Xu C., Huang M.T., Shen G., Yuan X., Lin W., Khor T.O., Conney A.H., Kong A.N. Inhibition of 7,12-dimethylbenz(a)anthracene-induced skin tumorigenesis in C57BL/6 mice by sulforaphane is mediated by nuclear factor E2-related factor 2. Cancer Res. 2006, 66:8293-8296.
138. Yu R., Chen C., Mo Y.Y., Hebbar V., Owuor E.D., Tan T.H., Kong A.N. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem. 2000, 275:39907-39913.
139. Zhang D.D., Lo S.C., Cross J.V., Templeton D.J., Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 2004, 24:10941-10953.
140. Zhang J., Hosoya T., Maruyama A., Nishikawa K., Maher J.M., Ohta T., Motohashi H., Fukamizu A., Shibahara S., Itoh K., Yamamoto M. Nrf2 Neh5 domain is differentially utilized in the transactivation of cytoprotective genes. Biochem. J. 2007, 404:459-466.
141. Zhao R., Yang B., Wang L., Xue P., Deng B., Zhang G., Jiang S., Zhang M., Liu M., Pi J., Guan D. Curcumin protects human keratinocytes against inorganic arsenite-induced acute cytotoxicity through an NRF2-dependent mechanism. Oxid. Med. Cell Longev. 2013, [Epub ahead of print].
142. Zhao Y., Xue Y., Oberley T.D., Kiningham K.K., Lin S.M., Yen H.C., Majima H., Hines J., St Clair D. Overexpression of manganese superoxide dismutase suppresses tumor formation by modulation of activator protein-1 signaling in a multistage skin carcinogenesis model. Cancer Res. 2001, 61:6082-6088.